TXG 10x Genomics, Inc.

NASDAQ
$51.80

10x Genomics, Inc. (TXG) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal Bearish Selling ran elevated versus TXG's own trailing one-year pace, with 50% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 5 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
25 transactions
Purchases
$0
0 shares
Sales
$12.6M
190,333 shares
Net activity
-$12.6M
purchases less sales

How much of that selling was preplanned? 50% planned / 50% discretionary

10b5-1 plan sales $6.3M 18 transactions · 89,804 shares
Discretionary sales $6.3M 7 transactions · 100,529 shares

Largest single sale: $2.0M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Saxonov Serge Chief Executive Officer Sell 31,000 $62.90 $1.9M 1,019,249 −3% of holding
Saxonov Serge 5 fills Chief Executive Officer Sell 10b5-1 25,000 $81.22 $2.0M 1,074,249 −2.3% of holding
SULIMAN SHEHNAAZ 5 fills Director Sell 10b5-1 5,723 $81.19 $464.7K 29,223 −16.4% of holding
Taich Adam 3 fills Chief Financial Officer Sell 10b5-1 46,388 $64.57 $3.0M 361,526 −11.4% of holding
STUELPNAGEL JOHN R 3 fills Director Sell 20,000 $61.75 $1.2M 341,424 −5.5% of holding
Saxonov Serge 3 fills Chief Executive Officer Sell 10b5-1 10,486 $63.69 $667.9K 1,082,335 −1% of holding
Saxonov Serge Chief Executive Officer Sell 18,545 $63.02 $1.2M 1,085,835 −1.7% of holding
Taich Adam Chief Financial Officer Sell 17,166 $63.02 $1.1M 362,732 −4.5% of holding
Hindson Benjamin J. See Remarks Sell 13,818 $63.02 $870.9K 488,182 −2.8% of holding
SULIMAN SHEHNAAZ 2 fills Director Sell 10b5-1 2,207 $63.65 $140.5K 31,161 −6.6% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.